Related Experiment Video
Updated: Jun 25, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Evidence-based choice of pneumatic lithotripsy probe diameter using an improvised in vitro biomodel
Pejman Shadpour1, Masood Etemadian, Abdolhossein Saeidi
1Hasheminejad Kidney Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. pshadpour@gmail.com
Purpose:
Over the past few years of experience at our center, we had perceived a difference in stone fragmentation capability between two probe diameters available for transurethral pneumatic lithotripsy. We designed and utilized a novel in vitro biomodel to test this hypothesis.
Materials And Methods:
Twenty 15-cm-long pieces of avian gut were refashioned and fixed at the two ends in a standardized manner to imitate the natural human ureter and its convolutions as closely as possible. Five-millimeter phantom stones placed at the proximal 5-cm point of each ureter were fragmented by pneumatic lithotripsy through a semirigid ureteroscope in four study groups: Group I, using a 1.6-mm probe at 12 Hz; group II, using the 1.6-mm probe at 6 Hz; group III using a 0.8-mm probe at 12 Hz; and group IV using the 0.8-mm probe at 6 Hz.
Results:
Fragmentation required 272 +/- 57 pulses on the 1.6-mm probe, versus 853 +/- 85 using the 0.8-mm probe (P < 0.005). The 1.6-mm probe was similarly effective at 6 and 12 Hz (P = 0.08), while for the 0.8-mm probe 6-Hz pulse frequency entailed far fewer pulses to achieve the objective (P < 0.005). The 1.6-mm probe had uniformly higher efficacy compared to 0.8 mm at both 6 and 12 Hz (P < 0.005).
Conclusion:
The 1.6-mm pneumatic lithotripsy probe has consistently higher efficacy compared to 0.8 mm throughout both frequency ranges. Our biomodel is introduced as a suitable low-cost and readily available in vitro medium for comparing intracorporeal lithotripsy modalities.